Evaluation of the genetic variant - 889 C > T Of Il-1α in migraine - partial analysis
DOI:
https://doi.org/10.48208/HeadacheMed.2021.45Keywords:
Migraine, Interleukin 1, Genetic polymorphism, PathophysiologyAbstract
Introduction
The pathophysiology of migraine integrates inflammatory and genetic aspects, with interleukin-1α being a component of this picture. This pro-inflammatory cytokine, responsible for inducing pyrogenic, hematological, and metabolic phenomena, is produced by macrophages and monocytes. Genetic variants, which can be found in the regulatory region of the gene for this substance, have clinical implications in different systems.
Objective
To evaluate the frequency of the -889C>T genetic variant of IL-1α and its association with clinical variables related to migraine.
Methods
Prospective case-control study composed of migraine patients and healthy controls aged between 18 and 60 years of age. Project approved by the Research Ethics Committee of PUCPR (No. 3,029,972). Demographic, clinical data on migraine classification and characteristics were collected using a structured form and validated questionnaires on anxiety (STAIY2), depression (BDI) and migraine-related disability (MIDAS). Genetic evaluation was performed with blood or saliva samples that were subjected to polymerase chain reaction (PCR), followed by electrophoresis in 1.5% agarose gel. Categorical data were analyzed by chi-square test or Fisher's exact test and continuous data by t-test or Mann-Whitney test.
Results
A total of 156 participants, 73 migraineurs and 83 controls, were evaluated. The -889C>T variant of IL-1α was not associated with increased susceptibility to migraine when evaluated in allelic, codominant, dominant, or recessive models. The C allele, the lowest producer of the cytokine, was associated with a higher frequency of osmophobia in patients with migraine (65.5% vs. 48.2%; p=0.038).
Conclusion
No association was identified between the -889C>T variant of IL-1α and susceptibility to migraine. Its effect on osmophobia should be further investigated. However, the present work is a partial analysis whose main limitation is the small sample size.
Downloads
References
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018;38(1):1-211 Doi:10.1177/0333102417738202 DOI: https://doi.org/10.1177/0333102417738202
Charles A. The pathophysiology of migraine: implications for clinical management. The Lancet Neurol 2018;17(2):174-182 Doi:10.1016/S1474-4422(17)30435-0 DOI: https://doi.org/10.1016/S1474-4422(17)30435-0
Burch R. Migraine and Tension-Type Headache: Diagnosis and Treatment. Med Clin North America 2019;103(2):215-233 Doi:10.1016/j.mcna.2018.10.003 DOI: https://doi.org/10.1016/j.mcna.2018.10.003
Speciali JG, Kowacs F, Jurno ME, Bruscky IS, Carvalho JJF, Malheiro FG, . . . Prado GF. Protocolo Nacional para Diagnóstico e Manejo das Cefaleias nas Unidades de Urgência do Brasil. Soc Bras Cefaleia 2018;1(1):3-14 [Internet] Available from: https://sbcefaleia.com.br/images/protocolo%20cefaleia%20urgencia.pdf
May A and Schulte LH. Chronic migraine: risk factors, mechanisms and treatment. Nat Rev Neurol 2016;12(8):455-464 Doi:10.1038/nrneurol.2016.93 DOI: https://doi.org/10.1038/nrneurol.2016.93
Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML and Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68(5):343 Doi:10.1212/01.wnl.0000252808.97649.21 DOI: https://doi.org/10.1212/01.wnl.0000252808.97649.21
Ates O, Kurt S, Altinisik J, Karaer H and Sezer S. Genetic variations in tumor necrosis factor alpha, interleukin-10 genes, and migraine susceptibility. Pain Med 2011;12(10):1464-1469 Doi:10.1111/j.1526-4637.2011.01200.x DOI: https://doi.org/10.1111/j.1526-4637.2011.01200.x
Persico AM, Verdecchia M, Pinzone V and Guidetti V. Migraine genetics: current findings and future lines of research. Neurogenetics 2015;16(2):77-95 Doi:10.1007/s10048-014-0433-x DOI: https://doi.org/10.1007/s10048-014-0433-x
Oliveira CM, Sakata RK, Issy AM, Gerola LR and Salomão R. Cytokines and pain. Rev Bras Anestesiol 2011;61(2):255-259, 260-255, 137-242 Doi:10.1016/s0034-7094(11)70029-0 DOI: https://doi.org/10.1590/S0034-70942011000200014
Rainero I, Pinessi L, Salani G, Valfrè W, Rivoiro C, Savi L, . . . Grimaldi LM. A polymorphism in the interleukin-1alpha gene influences the clinical features of migraine. Headache 2002;42(5):337-340 Doi:10.1046/j.1526-4610.2002.02103.x DOI: https://doi.org/10.1046/j.1526-4610.2002.02103.x
Mayer-Barber KD and Yan B. Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses. Cell Mol Immunol 2017;14(1):22-35 Doi:10.1038/cmi.2016.25 DOI: https://doi.org/10.1038/cmi.2016.25
Fragoso YD. MIDAS (Migraine Disability Assessment): a valuable tool for work-site identification of migraine in workers in Brazil. Sao Paulo Med J 2002;120(4):118-121 Doi:10.1590/s1516-31802002000400006 DOI: https://doi.org/10.1590/S1516-31802002000400006
Kosinski M, Bayliss MS, Bjorner JB, Ware JE, Jr., Garber WH, Batenhorst A, . . . Tepper S. A six-item short-form survey for measuring headache impact: the HIT-6. Qual Life Res 2003;12(8):963-974 Doi:10.1023/a:1026119331193 DOI: https://doi.org/10.1023/A:1026119331193
Spielberger CD, Gorsuch, R. L. y Lushene RE. C de ansiedad, Estado-Rasgo SMT. Manual STAI, Cuestionario de Ansiedad Estado Rasgo.Adaptación española. Tea Ediciones 1997;1(7):7-16
Bunce M, O'Neill CM, Barnardo MC, Krausa P, Browning MJ, Morris PJ and Welsh KI. Phototyping: comprehensive DNA typing for HLA-A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence-specific primers (PCR-SSP). Tissue Antigens 1995;46(5):355-367 Doi:10.1111/j.1399-0039.1995.tb03127.x DOI: https://doi.org/10.1111/j.1399-0039.1995.tb03127.x
Rist PM, Winter AC, Buring JE, Sesso HD and Kurth T. Migraine and the risk of incident hypertension among women. Cephalalgia 2018;38(12):1817-1824 Doi:10.1177/0333102418756865 DOI: https://doi.org/10.1177/0333102418756865
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Maria Paula Bertoletti Juliani, Amanda Brant Rocha, Giovana Ortiz Zendrini, Valéria Aparecida Bello, Regina Célia Poli Frederico, Aline Vitali da Silva
This work is licensed under a Creative Commons Attribution 4.0 International License.
